Found: 340
Select item for more details and to access through your institution.
Phase 1 study of sorafenib in combination with bortezomib in patients with advanced malignancies.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 5, p. 1201, doi. 10.1007/s10637-013-0004-2
- By:
- Publication type:
- Article
Increased complexity of t(11;14) rearrangements in plasma cell neoplasms compared with mantle cell lymphoma.
- Published in:
- Genes, Chromosomes & Cancer, 2021, v. 60, n. 10, p. 678, doi. 10.1002/gcc.22977
- By:
- Publication type:
- Article
Monoclonal gammopathy in the setting of Pyoderma gangrenosum.
- Published in:
- Archives of Dermatological Research, 2024, v. 316, n. 6, p. 1, doi. 10.1007/s00403-024-03098-7
- By:
- Publication type:
- Article
Three‐dimensional telomere profiling predicts risk of progression in smoldering multiple myeloma.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 8, p. 1532, doi. 10.1002/ajh.27364
- By:
- Publication type:
- Article
High‐risk multiple myeloma: Redefining genetic, clinical, and functional high‐risk disease in the era of molecular medicine and immunotherapy.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 8, p. 1560, doi. 10.1002/ajh.27327
- By:
- Publication type:
- Article
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL).
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 8, p. 1277, doi. 10.1002/ajh.26990
- By:
- Publication type:
- Article
Prevention of infections including vaccination strategies in multiple myeloma.
- Published in:
- American Journal of Hematology, 2023, v. 98, p. S46, doi. 10.1002/ajh.26766
- By:
- Publication type:
- Article
Dynamic monitoring of minimal residual disease in newly‐diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. E61, doi. 10.1002/ajh.26810
- By:
- Publication type:
- Article
Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 432, doi. 10.1002/ajh.26807
- By:
- Publication type:
- Article
Proposed risk‐scoring model for estimating the prognostic impact of 1q gain in patients with newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. 251, doi. 10.1002/ajh.26774
- By:
- Publication type:
- Article
Overexpression of the energy metabolism transcriptome within clonal plasma cells is associated with the pathogenesis and outcomes of patients with multiple myeloma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. 895, doi. 10.1002/ajh.26577
- By:
- Publication type:
- Article
Current approaches to management of newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2022, v. 97, p. S3, doi. 10.1002/ajh.26512
- By:
- Publication type:
- Article
Multicentric Castleman disease: A single center experience of treatment with a focus on autologous stem cell transplantation.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. 401, doi. 10.1002/ajh.26466
- By:
- Publication type:
- Article
Characteristics and risk factors for thrombosis in POEMS syndrome: A retrospective evaluation of 230 patients.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 2, p. 209, doi. 10.1002/ajh.26422
- By:
- Publication type:
- Article
Chimeric antigen receptor T‐cells, bispecific antibodies, and antibody‐drug conjugates for multiple myeloma: An update.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 1, p. 99, doi. 10.1002/ajh.26379
- By:
- Publication type:
- Article
Venetoclax for the treatment of multiple myeloma: Outcomes outside of clinical trials.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 9, p. 1131, doi. 10.1002/ajh.26269
- By:
- Publication type:
- Article
The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. 846, doi. 10.1002/ajh.26155
- By:
- Publication type:
- Article
Current approaches to management of high‐risk multiple myeloma.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. 854, doi. 10.1002/ajh.26161
- By:
- Publication type:
- Article
Use of endpoints in multiple myeloma randomized controlled trials over the last 15 years: A systematic review.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 6, p. 690, doi. 10.1002/ajh.26166
- By:
- Publication type:
- Article
Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post‐autologous stem cell transplantation lenalidomide maintenance therapy.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 5, p. E157, doi. 10.1002/ajh.26125
- By:
- Publication type:
- Article
Comparison of the current renal staging, progression and response criteria to predict renal survival in AL amyloidosis using a Mayo cohort.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 4, p. 446, doi. 10.1002/ajh.26092
- By:
- Publication type:
- Article
Outcomes of multiple myeloma patients with del 17p undergoing autologous stem cell transplantation.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 1, p. E35, doi. 10.1002/ajh.26023
- By:
- Publication type:
- Article
Overall survival of patients with triple‐class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 1, p. E5, doi. 10.1002/ajh.26010
- By:
- Publication type:
- Article
Daratumumab‐lenalidomide‐dexamethasone vs standard‐of‐care regimens: Efficacy in transplant‐ineligible untreated myeloma.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1486, doi. 10.1002/ajh.25963
- By:
- Publication type:
- Article
Characteristics of late transplant‐associated thrombotic microangiopathy in patients who underwent allogeneic hematopoietic stem cell transplantation.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 10, p. 1170, doi. 10.1002/ajh.25922
- By:
- Publication type:
- Article
Glycosylation of immunoglobulin light chains is highly prevalent in cold agglutinin disease.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. E222, doi. 10.1002/ajh.25843
- By:
- Publication type:
- Article
Role of imaging in multiple myeloma.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 8, p. 966, doi. 10.1002/ajh.25846
- By:
- Publication type:
- Article
Impact of minimal residual negativity using next generation flow cytometry on outcomes in light chain amyloidosis.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 5, p. 497, doi. 10.1002/ajh.25746
- By:
- Publication type:
- Article
Impact of MYD88<sup>L265P</sup> mutation status on histological transformation of Waldenström Macroglobulinemia.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. 274, doi. 10.1002/ajh.25697
- By:
- Publication type:
- Article
Hematopoietic score predicts outcomes in newly diagnosed multiple myeloma patients.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 1, p. 4, doi. 10.1002/ajh.25657
- By:
- Publication type:
- Article
Delayed neutrophil engraftment in patients receiving Daratumumab as part of their first induction regimen for multiple myeloma.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 1, p. E8, doi. 10.1002/ajh.25654
- By:
- Publication type:
- Article
Impact of consolidation therapy post autologous stem cell transplant in patients with light chain amyloidosis.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 10, p. 1066, doi. 10.1002/ajh.25572
- By:
- Publication type:
- Article
Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 9, p. 1020, doi. 10.1002/ajh.25566
- By:
- Publication type:
- Article
Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 5, p. E141, doi. 10.1002/ajh.25440
- By:
- Publication type:
- Article
Tetraploidy is associated with poor prognosis at diagnosis in multiple myeloma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 5, p. E117, doi. 10.1002/ajh.25420
- By:
- Publication type:
- Article
Reply to Castillo et al.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 3, p. E71, doi. 10.1002/ajh.25029
- By:
- Publication type:
- Article
Impact of involved free light chain (FLC) levels in patients achieving normal FLC ratio after initial therapy in light chain amyloidosis (AL).
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 1, p. 17, doi. 10.1002/ajh.24919
- By:
- Publication type:
- Article
Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trials.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 11, p. 1146, doi. 10.1002/ajh.24883
- By:
- Publication type:
- Article
Clinical presentation and outcomes of patients with type 1 monoclonal cryoglobulinemia.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 7, p. 668, doi. 10.1002/ajh.24745
- By:
- Publication type:
- Article
Hematology patient reported symptom screen to assess quality of life for AL amyloidosis.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 5, p. 435, doi. 10.1002/ajh.24676
- By:
- Publication type:
- Article
A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 5, p. 467, doi. 10.1002/ajh.24693
- By:
- Publication type:
- Article
Ixazomib cardiotoxicity: A possible class effect of proteasome inhibitors.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 2, p. 220, doi. 10.1002/ajh.24608
- By:
- Publication type:
- Article
Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 1, p. 50, doi. 10.1002/ajh.24582
- By:
- Publication type:
- Article
Outcomes of patients with renal monoclonal immunoglobulin deposition disease.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 11, p. 1123, doi. 10.1002/ajh.24528
- By:
- Publication type:
- Article
N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 11, p. 1129, doi. 10.1002/ajh.24532
- By:
- Publication type:
- Article
Induction therapy pre-autologous stem cell transplantation in immunoglobulin light chain amyloidosis: a retrospective evaluation.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 10, p. 984, doi. 10.1002/ajh.24453
- By:
- Publication type:
- Article
Long-term outcome of patients with POEMS syndrome: An update of the Mayo Clinic experience.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 6, p. 585, doi. 10.1002/ajh.24356
- By:
- Publication type:
- Article
Clinical characteristics and outcomes in biclonal gammopathies.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 5, p. 473, doi. 10.1002/ajh.24319
- By:
- Publication type:
- Article
Limiting early mortality: Do's and don'ts in the management of patients with newly diagnosed multiple myeloma.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 1, p. 101, doi. 10.1002/ajh.24129
- By:
- Publication type:
- Article
Bendamustine, lenalidomide, and dexamethasone (BRD) is highly effective with durable responses in relapsed multiple myeloma.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 12, p. 1106, doi. 10.1002/ajh.24181
- By:
- Publication type:
- Article